Michael S. von Bergwelt-Baildon Laboratory for Tumor and Transplantation Immunology and Stem Cell Transplantation Program University Hospital of Cologne, Department I of Internal Medicine Biography Publications Institution JoVE Articles Michael S. von Bergwelt-Baildon has not added a biography. If you are Michael S. von Bergwelt-Baildon and would like to personalize this page please email our Author Liaison for assistance. Publications The Cyclins: a Family of Widely Expressed Tumor Antigens? Expert Review of Vaccines. Mar, 2011 | Pubmed ID: 21434806 Targeting Malignant B Cells As Antigen-presenting Cells: TLR-9 Agonist Induces Systemic Regression of Lymphoma Expert Review of Vaccines. Mar, 2011 | Pubmed ID: 21434797 Potential of Toll-like Receptor 9 Agonists in Combined Anticancer Immunotherapy Strategies: Synergy of PAMPs and DAMPs? Immunotherapy. Mar, 2011 | Pubmed ID: 21395370 Toll-like Receptor 9 Agonists As Cancer Therapeutics Expert Opinion on Investigational Drugs. Mar, 2011 | Pubmed ID: 21254877 Cyclins Against Cancer: a Novel Family of Tumor Antigens? Immunotherapy. Sep, 2010 | Pubmed ID: 20874640 T-cell Responses to Cyclin B1 Are Not Restricted to P53-overexpressing Tumors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2009 | Pubmed ID: 19903794 The Role of B Cells in the Pathogenesis of Graft-versus-host Disease Blood. Dec, 2009 | Pubmed ID: 19749094 The Shared Tumor Associated Antigen Cyclin-A2 is Recognized by High-avidity T-cells International Journal of Cancer. Journal International Du Cancer. Nov, 2009 | Pubmed ID: 19681121 Nail Dystrophy Due to Dose-intensive Chemotherapy International Journal of Hematology. Jul, 2009 | Pubmed ID: 19543953 Using CD40-activated B Cells to Efficiently Identify Epitopes of Tumor Antigens Journal of Immunotherapy (Hagerstown, Md. : 1997). Feb-Mar, 2009 | Pubmed ID: 19238014 Cyclin D1-specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2008 | Pubmed ID: 18927298 Dendritic Cells Are Significantly Reduced in Non-Hodgkin's Lymphoma and Express Less CCR7 and CD62L Leukemia & Lymphoma. Apr, 2006 | Pubmed ID: 16690519 CD25 and Indoleamine 2,3-dioxygenase Are Up-regulated by Prostaglandin E2 and Expressed by Tumor-associated Dendritic Cells in Vivo: Additional Mechanisms of T-cell Inhibition Blood. Jul, 2006 | Pubmed ID: 16522817 Engagement of CD83 Ligand Induces Prolonged Expansion of CD8+ T Cells and Preferential Enrichment for Antigen Specificity Blood. Feb, 2006 | Pubmed ID: 16239433 Identification of a New HLA-A*0201-restricted Cryptic Epitope from CYP1B1 International Journal of Cancer. Journal International Du Cancer. Jun, 2005 | Pubmed ID: 15688394 DCs and CD40-activated B Cells: Current and Future Avenues to Cellular Cancer Immunotherapy Trends in Immunology. Dec, 2004 | Pubmed ID: 15530836 PH-triggered Microparticles for Peptide Vaccination Journal of Immunology (Baltimore, Md. : 1950). Aug, 2004 | Pubmed ID: 15294974 O-Linked Glycans Control Glycoprotein Processing by Antigen-presenting Cells: a Biochemical Approach to the Molecular Aspects of MUC1 Processing by Dendritic Cells European Journal of Immunology. Dec, 2003 | Pubmed ID: 14635032 Autoantibodies Frequently Detected in Patients with Aplastic Anemia Blood. Dec, 2003 | Pubmed ID: 12947009 The Shared Tumor-associated Antigen Cytochrome P450 1B1 is Recognized by Specific Cytotoxic T Cells Blood. Nov, 2003 | Pubmed ID: 12869499 Viral Antigen-specific CD8+ T-cell Responses Are Impaired in Multiple Myeloma British Journal of Haematology. Jun, 2003 | Pubmed ID: 12786794 Human Primary and Memory Cytotoxic T Lymphocyte Responses Are Efficiently Induced by Means of CD40-activated B Cells As Antigen-presenting Cells: Potential for Clinical Application Blood. May, 2002 | Pubmed ID: 11964299 Generering av Human CD40-aktiverade B-celler Tanja M. Liebig1, Anne Fiedler1, Shahram Zoghi1, Alexander Shimabukuro-Vornhagen1, Michael S. von Bergwelt-Baildon1 1Laboratory for Tumor and Transplantation Immunology and Stem Cell Transplantation Program, University Hospital of Cologne, Department I of Internal Medicine JoVE 1373 생물학
Generering av Human CD40-aktiverade B-celler Tanja M. Liebig1, Anne Fiedler1, Shahram Zoghi1, Alexander Shimabukuro-Vornhagen1, Michael S. von Bergwelt-Baildon1 1Laboratory for Tumor and Transplantation Immunology and Stem Cell Transplantation Program, University Hospital of Cologne, Department I of Internal Medicine JoVE 1373 생물학